Stay updated on MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Sign up to get notified when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.

Latest updates to the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check54 days agoChange DetectedThe study has transitioned from a Phase 1/2 to a Phase 1 study, with a new start date of May 6, 2025, and a reduction in the number of locations from 21 to 24. Additionally, the sponsor has changed from Mirati Therapeutics Inc. to Bristol-Myers Squibb.SummaryDifference14%
- Check61 days agoChange DetectedThe web page has been updated to a new version, v2.15.2, replacing the previous version v2.15.0.SummaryDifference0.2%
- Check75 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed descriptions of a clinical trial for MRTX1719 and the addition of new identifiers and conditions related to the study.SummaryDifference17%
Stay in the know with updates to MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX1719 in Solid Tumors With MTAP Deletion Clinical Trial page.